These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10464608)

  • 21. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing.
    Schuchman EH; Miranda SR
    Genet Test; 1997; 1(1):13-9. PubMed ID: 10464620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded carrier screening in the Ashkenazi Jewish population.
    Mitchell J
    Hum Mutat; 2010 Nov; 31(11):v. PubMed ID: 21043044
    [No Abstract]   [Full Text] [Related]  

  • 24. Ashkenazi Jewish genetic disease carrier screening.
    Begleiter ML; Buchholz JL; Atherton AM; Mays LZ; Lund MM; Strenk ME
    Genet Med; 2008 Jun; 10(6):461; author reply 461-2. PubMed ID: 18496229
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
    Eng CM; Desnick RJ
    Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to ACMG guideline: carrier screening in individuals of Ashkenazi Jewish decent.
    Levy-Lahad E; Zuckerman S; Sagi M
    Genet Med; 2008 Jun; 10(6):462; author reply 463. PubMed ID: 18496217
    [No Abstract]   [Full Text] [Related]  

  • 28. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
    Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
    Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
    Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.
    Haque IS; Lazarin GA; Kang HP; Evans EA; Goldberg JD; Wapner RJ
    JAMA; 2016 Aug; 316(7):734-42. PubMed ID: 27533158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
    Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
    Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory.
    Strom CM; Crossley B; Redman JB; Quan F; Buller A; McGinniss MJ; Sun W
    Genet Med; 2004; 6(3):145-52. PubMed ID: 15354333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some genetics for some Jews: a Jewish look at the human genome.
    Pollack R
    Conserv Jud; 2002; 54(3):3-12. PubMed ID: 12735297
    [No Abstract]   [Full Text] [Related]  

  • 35. The possibility of a selection process in the Ashkenazi Jewish population.
    Zlotogora J; Bach G
    Am J Hum Genet; 2003 Aug; 73(2):438-40; author reply 440-1. PubMed ID: 12868052
    [No Abstract]   [Full Text] [Related]  

  • 36. Human genetics. Jewish lysosomes.
    Diamond JM
    Nature; 1994 Mar; 368(6469):291-2. PubMed ID: 8127362
    [No Abstract]   [Full Text] [Related]  

  • 37. Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent.
    Strom CM; Janeczko RA; Anderson B; Redman J; Quan F; Buller A; McGinniss MJ; Sun WM
    Genet Med; 2005; 7(9):633-9. PubMed ID: 16301865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.
    Wang ZH; Zeng B; Pastores GM; Raksadawan N; Ong E; Kolodny EH
    Genet Test; 2001; 5(2):87-92. PubMed ID: 11551108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis in Jews: frequency and mutation distribution.
    Kerem B; Chiba-Falek O; Kerem E
    Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.